Lv6
1630 积分 2022-09-14 加入
Novel drug targets in 2025
17天前
已完结
The evolving landscape of drug targets
17天前
已完结
SUN-730 TYRA-300 Promotes Bone Growth In Two Mouse Models Of FGFR3-related Skeletal Dysplasia
1个月前
已关闭
803 Anti-tumor activity of RAS(ON) multi-selective inhibitor RMC-6236 and anti-PD-1 combination in immunologically heterogeneous preclinical PDAC models
2个月前
已完结
Chemoproteomics-guided development of SLC15A4 inhibitors with anti-inflammatory activity
2个月前
已完结
In vivo CAR T cells move into clinical trials
7个月前
已完结
Loss-of-function mutations in PLD4 lead to systemic lupus erythematosus
9个月前
已完结
ABT, Elacridar and Bile‐Duct Cannulated Rats: Tools to Understand Pharmacokinetics
11个月前
已完结
Combining the farnesyltransferase inhibitor lonafarnib with paclitaxel results in enhanced growth inhibitory effects on human ovarian cancer models in vitro and in vivo
11个月前
已完结
A first-in-class CDK4 inhibitor demonstrates in vitro, ex-vivo and in vivo efficacy against ovarian cancer
1年前
已完结
皖公网安备34019202002308
